Skip to content
NEWSR
Business · 5 min read

Therabody Recall: Affected Theragun PRO Chargers and Next Steps

The FDA lists an open recall for certain fourth-generation Theragun PRO charging cradles linked to fire and overheating reports. Here is how to identify the charger, what to do now and what remains unresolved.

Harris Eugene
· Updated
In this story
Therabody Recall: Affected Theragun PRO Chargers and Next Steps

Key takeaways

  • The FDA recall covers specified fourth-generation Theragun PRO charging cradles, including listed SKUs, UDI-DI 00810036050135 and GTIN 810036051378.
  • The reported hazard is overheating while charging the removable battery pack, with reports alleging fires, smoke, melting, burns and burning odors.
  • Owners should verify the charger, stop using a matching unit and seek confirmed instructions from Therabody.
  • No consumer refund, replacement program, claim administrator or verified deadline is established in the supplied evidence.
  • The proposed class action is an allegation, not a settlement or finding of liability.

Owners of certain fourth-generation Theragun PRO massage devices in the United States may be affected by an open FDA recall of the charging cradle. The recalled charger may overheat while charging the device’s removable battery pack, creating a potential fire hazard; the FDA record cites reports alleging fires, visible smoke, melting, charger burns, burning odors and overheating. No verified consumer claim or refund deadline appears in the supplied evidence. The next step is to identify the charger and stop using it until Therabody provides confirmed instructions.

Which Theragun PRO chargers are included

The FDA lists the recalled product as the charger for the Therabody Theragun G4 PRO massage device and products that include the fourth-generation Theragun PRO charger. The listed product identifiers are:

  • G4 PRO Black US – Refurb., SKU TG02428-01
  • G4 PRO NA, SKU G4-PRO-PKG-NA
  • G4-PRO-PKG-US, listed as G4 PRO US
  • G4 PRO Black US – Refurb V, SKU TG0002428-1V10
  • Pro Charger Single Unit, SKU PRO-CHARGER-SINGLE
  • UDI-DI 00810036050135
  • GTIN 810036051378

The FDA says all lots are recalled and that production ended in 2022. The recall record lists nationwide distribution in the United States and a quantity in commerce of 584,224. Those identifiers apply to the charging cradle, not necessarily every Therabody product or every Theragun accessory.

Why the recall matters

The mechanism described by the FDA is specific: the charging cradle may overheat while charging the removable battery pack. That creates a thermal-event risk, which is the safety issue consumers need to weigh before plugging in the charger. The FDA also says the firm’s cause determination remains under investigation, so the agency’s record establishes the recalled product and reported hazard but does not explain the final engineering cause.

This distinction matters because the recall is not evidence that every unit will catch fire. It does mean the charger belongs to an identified product group for which the agency has recorded fire-related reports. A consumer cannot safely resolve that uncertainty by relying only on whether a particular charger has previously appeared normal.

What owners should do now

A report by The Cool Down, quoting a Therabody statement, says the company advised customers to discontinue use of affected chargers immediately and provided the email address the official administrator for questions. Because the supplied evidence does not include a direct Therabody consumer notice, readers should treat that instruction as a reported company position and verify any replacement or return process directly with the company.

Do not throw the charger away or ship it somewhere without instructions. The FDA notice tells distributors, retailers and resellers to stop selling, distributing or transferring the charger, remove it from shelves and online listings, and segregate inventory. That part of the notice is directed at commercial recipients, not a complete consumer disposal guide. Until a consumer remedy is published, keep the charger away from use and follow any later return, repair or replacement directions.

If you still have the packaging, compare its SKU and other identifiers with the FDA record. If you bought a Theragun PRO device without the original packaging, check the charger itself for identifying information and ask Therabody to confirm whether it is included. Keep purchase records, photographs of the charger and any communications about the recall. The evidence does not establish that consumers must submit those documents, but they could help if the company later announces a warranty, replacement or refund process.

What the lawsuit does—and does not—establish

A proposed class action filed by Raymond Cid in the U.S. District Court for the Central District of California alleges that Therabody sold Theragun PRO devices with charging cradles that could overheat or catch fire and did not provide an adequate consumer remedy. The complaint, as described by Claim Depot, is an allegation rather than a court finding. It does not establish liability, class membership or a payment amount.

The lawsuit also should not be confused with a settlement. The supplied evidence identifies no approved settlement, claims administrator, payment estimate, objection deadline or claim-filing deadline. Consumers should not assume that owning an affected charger creates an automatic right to money, or that filing a lawsuit-related claim would guarantee payment.

The unresolved consumer question

The FDA record says Therabody is evaluating and addressing the issue, but it does not list a completed replacement, repair or refund program. That is the practical gap for owners: the safety warning identifies what may be wrong, while the available evidence does not yet establish how consumers will be made whole or how they should return the charger.

For now, the defensible action is to verify the identifiers, stop using a matching charger, preserve purchase information and seek instructions through the reported company contact. The next meaningful milestone will be a direct Therabody or regulator notice that explains the remedy and any eligibility or deadline. Until then, the recall supports a safety action, not a confirmed refund claim.

Newsr Reframed

This is both a safety recall and a remedy-availability story. The FDA provides unusually concrete identifiers and confirms nationwide distribution, giving owners a practical way to check whether their charger is included. The evidence also leaves a material gap: it does not show a completed consumer refund, replacement or repair process, and the lawsuit has not produced a settlement or payment schedule. Readers should separate the immediate safety step—stop using a matching charger—from the unresolved financial question of whether Therabody will offer compensation and under what terms.

Sources and methodology

Share this story Facebook X LinkedIn Reddit WhatsApp Email

Latest stories